BeiGene Ltd (ONC)
250.98
-2.22
(-0.88%)
USD |
NASDAQ |
Mar 25, 16:00
250.98
0.00 (0.00%)
After-Hours: 20:00
BeiGene Total Liabilities (Quarterly): 2.589B for Dec. 31, 2024
View 4,000+ Financial Data Types:
Add
Browse
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Gilead Sciences Inc | 39.75B |
| Leap Therapeutics Inc | 16.09M |
| Catalyst Pharmaceuticals Inc | 123.78M |
| Exelixis Inc | 703.49M |
| Halozyme Therapeutics Inc | 1.700B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 5.921B |
| Shareholders Equity (Quarterly) | 3.332B |
| Debt to Equity Ratio | 0.3055 |
| Current Ratio | 1.802 |
| Net Debt Paydown Yield | -0.50% |